<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Allogene Therapeutics, Inc. (ALLO) - Company Filings</title>
    <link>https://www.developersdigest.tech/markets/allo/filings</link>
    <description>Latest company filings for Allogene Therapeutics, Inc. (ALLO) - annual reports, quarterly reports, major events, and insider trades, newest first.</description>
    <language>en</language>
    <lastBuildDate>Sun, 12 Jul 2026 22:52:47 GMT</lastBuildDate>
    <atom:link href="https://www.developersdigest.tech/markets/allo/filings/feed.xml" rel="self" type="application/rss+xml" />
    <item>
      <title><![CDATA[ALLO: Proxy materials (DEFA14A)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1737287/000162828026036992/allo-20260520xdefa14a.htm</link>
      <guid isPermaLink="false">0001628280-26-036992</guid>
      <description><![CDATA[Allogene Therapeutics, Inc. filed a Proxy materials (DEFA14A) on 2026-05-21.]]></description>
      <pubDate>Thu, 21 May 2026 12:00:00 GMT</pubDate>
      <category>DEFA14A</category>
    </item>
    <item>
      <title><![CDATA[ALLO: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1737287/000110465926062730/xslSCHEDULE_13G_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0001104659-26-062730</guid>
      <description><![CDATA[Allogene Therapeutics, Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-05-15.]]></description>
      <pubDate>Fri, 15 May 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[ALLO: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1737287/000090266426002534/xslSCHEDULE_13G_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0000902664-26-002534</guid>
      <description><![CDATA[Allogene Therapeutics, Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-05-15.]]></description>
      <pubDate>Fri, 15 May 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[ALLO: Quarterly report (10-Q)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1737287/000162828026034585/allo-20260331.htm</link>
      <guid isPermaLink="false">0001628280-26-034585</guid>
      <description><![CDATA[Allogene Therapeutics, Inc. filed a Quarterly report (10-Q) on 2026-05-13.]]></description>
      <pubDate>Wed, 13 May 2026 12:00:00 GMT</pubDate>
      <category>10-Q</category>
    </item>
    <item>
      <title><![CDATA[ALLO: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1737287/000162828026034583/allo-20260512.htm</link>
      <guid isPermaLink="false">0001628280-26-034583</guid>
      <description><![CDATA[Allogene Therapeutics, Inc. filed a Major company event (8-K) on 2026-05-13.]]></description>
      <pubDate>Wed, 13 May 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[ALLO: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1737287/000161102426000005/xslSCHEDULE_13G_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0001611024-26-000005</guid>
      <description><![CDATA[Allogene Therapeutics, Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-05-13.]]></description>
      <pubDate>Wed, 13 May 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[ALLO: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1737287/000129654926000006/xslSCHEDULE_13G_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0001296549-26-000006</guid>
      <description><![CDATA[Allogene Therapeutics, Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-05-13.]]></description>
      <pubDate>Wed, 13 May 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[ALLO: Annual report to shareholders (ARS)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1737287/000162828026028957/allogenetherapeuticsinc_x2.pdf</link>
      <guid isPermaLink="false">0001628280-26-028957</guid>
      <description><![CDATA[Allogene Therapeutics, Inc. filed a Annual report to shareholders (ARS) on 2026-04-30.]]></description>
      <pubDate>Thu, 30 Apr 2026 12:00:00 GMT</pubDate>
      <category>ARS</category>
    </item>
    <item>
      <title><![CDATA[ALLO: Proxy materials (DEFA14A)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1737287/000162828026028953/allo-20260430xdefa14axnoti.htm</link>
      <guid isPermaLink="false">0001628280-26-028953</guid>
      <description><![CDATA[Allogene Therapeutics, Inc. filed a Proxy materials (DEFA14A) on 2026-04-30.]]></description>
      <pubDate>Thu, 30 Apr 2026 12:00:00 GMT</pubDate>
      <category>DEFA14A</category>
    </item>
    <item>
      <title><![CDATA[ALLO: Proxy statement (DEF 14A)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1737287/000162828026028948/allo-20260430.htm</link>
      <guid isPermaLink="false">0001628280-26-028948</guid>
      <description><![CDATA[Allogene Therapeutics, Inc. filed a Proxy statement (DEF 14A) on 2026-04-30.]]></description>
      <pubDate>Thu, 30 Apr 2026 12:00:00 GMT</pubDate>
      <category>DEF 14A</category>
    </item>
    <item>
      <title><![CDATA[ALLO: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1737287/000183520826000003/xslF345X06/wk-form4_1776975369.xml</link>
      <guid isPermaLink="false">0001835208-26-000003</guid>
      <description><![CDATA[Allogene Therapeutics, Inc. filed a Insider trade (4) on 2026-04-23.]]></description>
      <pubDate>Thu, 23 Apr 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ALLO: SCHEDULE 13G]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1737287/000123191926000398/xslSCHEDULE_13G_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0001231919-26-000398</guid>
      <description><![CDATA[Allogene Therapeutics, Inc. filed a SCHEDULE 13G (SCHEDULE 13G) on 2026-04-23.]]></description>
      <pubDate>Thu, 23 Apr 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G</category>
    </item>
    <item>
      <title><![CDATA[ALLO: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1737287/000183520826000001/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001835208-26-000001</guid>
      <description><![CDATA[Allogene Therapeutics, Inc. filed a Insider sale notice (144) on 2026-04-21.]]></description>
      <pubDate>Tue, 21 Apr 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[ALLO: PRE 14A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1737287/000162828026026053/allo-20260420.htm</link>
      <guid isPermaLink="false">0001628280-26-026053</guid>
      <description><![CDATA[Allogene Therapeutics, Inc. filed a PRE 14A (PRE 14A) on 2026-04-20.]]></description>
      <pubDate>Mon, 20 Apr 2026 12:00:00 GMT</pubDate>
      <category>PRE 14A</category>
    </item>
    <item>
      <title><![CDATA[ALLO: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1737287/000119312526157140/d283634d8k.htm</link>
      <guid isPermaLink="false">0001193125-26-157140</guid>
      <description><![CDATA[Allogene Therapeutics, Inc. filed a Major company event (8-K) on 2026-04-15.]]></description>
      <pubDate>Wed, 15 Apr 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[ALLO: Prospectus supplement (424B5)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1737287/000119312526157128/d112190d424b5.htm</link>
      <guid isPermaLink="false">0001193125-26-157128</guid>
      <description><![CDATA[Allogene Therapeutics, Inc. filed a Prospectus supplement (424B5) on 2026-04-15.]]></description>
      <pubDate>Wed, 15 Apr 2026 12:00:00 GMT</pubDate>
      <category>424B5</category>
    </item>
    <item>
      <title><![CDATA[ALLO: Prospectus supplement (424B5)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1737287/000119312526152989/d112190d424b5.htm</link>
      <guid isPermaLink="false">0001193125-26-152989</guid>
      <description><![CDATA[Allogene Therapeutics, Inc. filed a Prospectus supplement (424B5) on 2026-04-13.]]></description>
      <pubDate>Mon, 13 Apr 2026 12:00:00 GMT</pubDate>
      <category>424B5</category>
    </item>
    <item>
      <title><![CDATA[ALLO: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1737287/000119312526152866/d249901d8k.htm</link>
      <guid isPermaLink="false">0001193125-26-152866</guid>
      <description><![CDATA[Allogene Therapeutics, Inc. filed a Major company event (8-K) on 2026-04-13.]]></description>
      <pubDate>Mon, 13 Apr 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[ALLO: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1737287/000119312526151999/d49895d8k.htm</link>
      <guid isPermaLink="false">0001193125-26-151999</guid>
      <description><![CDATA[Allogene Therapeutics, Inc. filed a Major company event (8-K) on 2026-04-13.]]></description>
      <pubDate>Mon, 13 Apr 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[ALLO: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1737287/000205791826000007/xslF345X06/wk-form4_1775162856.xml</link>
      <guid isPermaLink="false">0002057918-26-000007</guid>
      <description><![CDATA[Allogene Therapeutics, Inc. filed a Insider trade (4) on 2026-04-02.]]></description>
      <pubDate>Thu, 02 Apr 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ALLO: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1737287/000205791826000005/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0002057918-26-000005</guid>
      <description><![CDATA[Allogene Therapeutics, Inc. filed a Insider sale notice (144) on 2026-04-01.]]></description>
      <pubDate>Wed, 01 Apr 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[ALLO: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1737287/000173728726000015/xslF345X06/wk-form4_1773864406.xml</link>
      <guid isPermaLink="false">0001737287-26-000015</guid>
      <description><![CDATA[Allogene Therapeutics, Inc. filed a Insider trade (4) on 2026-03-18.]]></description>
      <pubDate>Wed, 18 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ALLO: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1737287/000173728726000013/xslF345X06/wk-form4_1773864344.xml</link>
      <guid isPermaLink="false">0001737287-26-000013</guid>
      <description><![CDATA[Allogene Therapeutics, Inc. filed a Insider trade (4) on 2026-03-18.]]></description>
      <pubDate>Wed, 18 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ALLO: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1737287/000205791826000004/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0002057918-26-000004</guid>
      <description><![CDATA[Allogene Therapeutics, Inc. filed a Insider sale notice (144) on 2026-03-16.]]></description>
      <pubDate>Mon, 16 Mar 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[ALLO: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1737287/000161102426000003/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001611024-26-000003</guid>
      <description><![CDATA[Allogene Therapeutics, Inc. filed a Insider sale notice (144) on 2026-03-16.]]></description>
      <pubDate>Mon, 16 Mar 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[ALLO: Employee stock plan (S-8)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1737287/000162828026017307/allogene-formsx8x20260312.htm</link>
      <guid isPermaLink="false">0001628280-26-017307</guid>
      <description><![CDATA[Allogene Therapeutics, Inc. filed a Employee stock plan (S-8) on 2026-03-12.]]></description>
      <pubDate>Thu, 12 Mar 2026 12:00:00 GMT</pubDate>
      <category>S-8</category>
    </item>
    <item>
      <title><![CDATA[ALLO: Annual report (10-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1737287/000162828026017242/allo-20251231.htm</link>
      <guid isPermaLink="false">0001628280-26-017242</guid>
      <description><![CDATA[Allogene Therapeutics, Inc. filed a Annual report (10-K) on 2026-03-12.]]></description>
      <pubDate>Thu, 12 Mar 2026 12:00:00 GMT</pubDate>
      <category>10-K</category>
    </item>
    <item>
      <title><![CDATA[ALLO: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1737287/000162828026017230/allo-20260312.htm</link>
      <guid isPermaLink="false">0001628280-26-017230</guid>
      <description><![CDATA[Allogene Therapeutics, Inc. filed a Major company event (8-K) on 2026-03-12.]]></description>
      <pubDate>Thu, 12 Mar 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[ALLO: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1737287/000205791826000003/xslF345X05/wk-form4_1772664133.xml</link>
      <guid isPermaLink="false">0002057918-26-000003</guid>
      <description><![CDATA[Allogene Therapeutics, Inc. filed a Insider trade (4) on 2026-03-04.]]></description>
      <pubDate>Wed, 04 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ALLO: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1737287/000205791826000001/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0002057918-26-000001</guid>
      <description><![CDATA[Allogene Therapeutics, Inc. filed a Insider sale notice (144) on 2026-03-02.]]></description>
      <pubDate>Mon, 02 Mar 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[ALLO: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1737287/000129654926000004/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001296549-26-000004</guid>
      <description><![CDATA[Allogene Therapeutics, Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-02-17.]]></description>
      <pubDate>Tue, 17 Feb 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[ALLO: SCHEDULE 13G]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1737287/000161102426000002/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001611024-26-000002</guid>
      <description><![CDATA[Allogene Therapeutics, Inc. filed a SCHEDULE 13G (SCHEDULE 13G) on 2026-02-13.]]></description>
      <pubDate>Fri, 13 Feb 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G</category>
    </item>
    <item>
      <title><![CDATA[ALLO: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1737287/000173728726000011/xslF345X05/wk-form4_1770243619.xml</link>
      <guid isPermaLink="false">0001737287-26-000011</guid>
      <description><![CDATA[Allogene Therapeutics, Inc. filed a Insider trade (4) on 2026-02-04.]]></description>
      <pubDate>Wed, 04 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ALLO: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1737287/000173728726000009/xslF345X05/wk-form4_1770243495.xml</link>
      <guid isPermaLink="false">0001737287-26-000009</guid>
      <description><![CDATA[Allogene Therapeutics, Inc. filed a Insider trade (4) on 2026-02-04.]]></description>
      <pubDate>Wed, 04 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ALLO: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1737287/000173728726000007/xslF345X05/wk-form4_1770243376.xml</link>
      <guid isPermaLink="false">0001737287-26-000007</guid>
      <description><![CDATA[Allogene Therapeutics, Inc. filed a Insider trade (4) on 2026-02-04.]]></description>
      <pubDate>Wed, 04 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ALLO: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1737287/000173728726000005/xslF345X05/wk-form4_1770242977.xml</link>
      <guid isPermaLink="false">0001737287-26-000005</guid>
      <description><![CDATA[Allogene Therapeutics, Inc. filed a Insider trade (4) on 2026-02-04.]]></description>
      <pubDate>Wed, 04 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ALLO: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1737287/000173728726000002/xslF345X05/wk-form4_1770242855.xml</link>
      <guid isPermaLink="false">0001737287-26-000002</guid>
      <description><![CDATA[Allogene Therapeutics, Inc. filed a Insider trade (4) on 2026-02-04.]]></description>
      <pubDate>Wed, 04 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ALLO: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1737287/000136215526000002/xslF345X05/wk-form4_1770243135.xml</link>
      <guid isPermaLink="false">0001362155-26-000002</guid>
      <description><![CDATA[Allogene Therapeutics, Inc. filed a Insider trade (4) on 2026-02-04.]]></description>
      <pubDate>Wed, 04 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ALLO: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1737287/000129654926000002/xslF345X05/wk-form4_1770242650.xml</link>
      <guid isPermaLink="false">0001296549-26-000002</guid>
      <description><![CDATA[Allogene Therapeutics, Inc. filed a Insider trade (4) on 2026-02-04.]]></description>
      <pubDate>Wed, 04 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ALLO: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1737287/000195004726000851/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001950047-26-000851</guid>
      <description><![CDATA[Allogene Therapeutics, Inc. filed a Insider sale notice (144) on 2026-02-02.]]></description>
      <pubDate>Mon, 02 Feb 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[ALLO: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1737287/000195004726000850/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001950047-26-000850</guid>
      <description><![CDATA[Allogene Therapeutics, Inc. filed a Insider sale notice (144) on 2026-02-02.]]></description>
      <pubDate>Mon, 02 Feb 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[ALLO: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1737287/000195004726000849/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001950047-26-000849</guid>
      <description><![CDATA[Allogene Therapeutics, Inc. filed a Insider sale notice (144) on 2026-02-02.]]></description>
      <pubDate>Mon, 02 Feb 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[ALLO: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1737287/000195004726000848/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001950047-26-000848</guid>
      <description><![CDATA[Allogene Therapeutics, Inc. filed a Insider sale notice (144) on 2026-02-02.]]></description>
      <pubDate>Mon, 02 Feb 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[ALLO: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1737287/000195004726000843/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001950047-26-000843</guid>
      <description><![CDATA[Allogene Therapeutics, Inc. filed a Insider sale notice (144) on 2026-02-02.]]></description>
      <pubDate>Mon, 02 Feb 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[ALLO: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1737287/000195004726000842/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001950047-26-000842</guid>
      <description><![CDATA[Allogene Therapeutics, Inc. filed a Insider sale notice (144) on 2026-02-02.]]></description>
      <pubDate>Mon, 02 Feb 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[ALLO: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1737287/000185104426000003/xslF345X05/wk-form4_1769202908.xml</link>
      <guid isPermaLink="false">0001851044-26-000003</guid>
      <description><![CDATA[Allogene Therapeutics, Inc. filed a Insider trade (4) on 2026-01-23.]]></description>
      <pubDate>Fri, 23 Jan 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ALLO: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1737287/000185104426000001/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001851044-26-000001</guid>
      <description><![CDATA[Allogene Therapeutics, Inc. filed a Insider sale notice (144) on 2026-01-21.]]></description>
      <pubDate>Wed, 21 Jan 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[ALLO: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1737287/000122135525000005/xslF345X05/wk-form4_1766447828.xml</link>
      <guid isPermaLink="false">0001221355-25-000005</guid>
      <description><![CDATA[Allogene Therapeutics, Inc. filed a Insider trade (4) on 2025-12-22.]]></description>
      <pubDate>Mon, 22 Dec 2025 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ALLO: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1737287/000173728725000094/xslF345X05/wk-form4_1763586562.xml</link>
      <guid isPermaLink="false">0001737287-25-000094</guid>
      <description><![CDATA[Allogene Therapeutics, Inc. filed a Insider trade (4) on 2025-11-19.]]></description>
      <pubDate>Wed, 19 Nov 2025 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[ALLO: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1737287/000205791825000002/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0002057918-25-000002</guid>
      <description><![CDATA[Allogene Therapeutics, Inc. filed a Insider sale notice (144) on 2025-11-17.]]></description>
      <pubDate>Mon, 17 Nov 2025 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
  </channel>
</rss>